MAIA Biotechnology: posts presentation and summary

What happened MAIA Biotechnology, Inc. announced that it has prepared a presentation (the “Presentation”) and a summary (the “Summary”) that management intends to use in presentations about the company’s operations and performance on or after Oct 6, 2026, and that both were posted to the company’s website on Oct 6, 2026. The filing states that each of the Presentation and the Summary speaks as of the date of the report and that each contains forward-looking statements; the company also states it may update them in the future but disclaims any obligation to do so and that the materials are not “filed” for purposes of Section 18 of the Exchange Act.

Key details

• Presentation and Summary posted to the company website on Oct 6, 2026.
• Management intends to use the Presentation and Summary in presentations on or after Oct 6, 2026.
• The materials contain forward-looking statements and the filing lists example risk areas, including clinical study timing and results, regulatory filings and approvals, manufacturing and commercialization, market acceptance, and intellectual property protection.
• The company says the materials speak as of the report date and that it undertakes no obligation to publicly update forward-looking statements except as required by law.

Why it may matter This is Item 7.01: Regulation FD disclosure, which covers disclosure of presentation materials and related forward-looking statements. The filing does not show why the insider traded or why the company acted.